Correlation Between Guangdong Shenglu and Eyebright Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Guangdong Shenglu and Eyebright Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Guangdong Shenglu and Eyebright Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Guangdong Shenglu Telecommunication and Eyebright Medical Technology, you can compare the effects of market volatilities on Guangdong Shenglu and Eyebright Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Guangdong Shenglu with a short position of Eyebright Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Guangdong Shenglu and Eyebright Medical.

Diversification Opportunities for Guangdong Shenglu and Eyebright Medical

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Guangdong and Eyebright is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Guangdong Shenglu Telecommunic and Eyebright Medical Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyebright Medical and Guangdong Shenglu is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Guangdong Shenglu Telecommunication are associated (or correlated) with Eyebright Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyebright Medical has no effect on the direction of Guangdong Shenglu i.e., Guangdong Shenglu and Eyebright Medical go up and down completely randomly.

Pair Corralation between Guangdong Shenglu and Eyebright Medical

Assuming the 90 days trading horizon Guangdong Shenglu Telecommunication is expected to generate 0.83 times more return on investment than Eyebright Medical. However, Guangdong Shenglu Telecommunication is 1.2 times less risky than Eyebright Medical. It trades about 0.07 of its potential returns per unit of risk. Eyebright Medical Technology is currently generating about 0.04 per unit of risk. If you would invest  605.00  in Guangdong Shenglu Telecommunication on September 27, 2024 and sell it today you would earn a total of  67.00  from holding Guangdong Shenglu Telecommunication or generate 11.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Guangdong Shenglu Telecommunic  vs.  Eyebright Medical Technology

 Performance 
       Timeline  
Guangdong Shenglu 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Guangdong Shenglu Telecommunication are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Guangdong Shenglu sustained solid returns over the last few months and may actually be approaching a breakup point.
Eyebright Medical 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Eyebright Medical Technology are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Eyebright Medical may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Guangdong Shenglu and Eyebright Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Guangdong Shenglu and Eyebright Medical

The main advantage of trading using opposite Guangdong Shenglu and Eyebright Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Guangdong Shenglu position performs unexpectedly, Eyebright Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyebright Medical will offset losses from the drop in Eyebright Medical's long position.
The idea behind Guangdong Shenglu Telecommunication and Eyebright Medical Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance